Maris William J

CIK 00017222105 companiesCARDIFF-BY-THE-SEA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001722210

Recent Transactions

27 trades

Sale
Dave Inc./DE$DAVE
Class A Common Stock
2024-10-09$40.60/sh−1,000,000→ 1,028,232 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2024-05-10$48.90/sh−110,000→ 2,028,232 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2024-05-07$48.90/sh−450,000→ 2,138,232 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2023-08-08$5.73/sh−297,771→ 2,588,232 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2022-09-30$0.36/sh−97,300→ 92,352,107 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2022-09-29$0.35/sh−400,974→ 92,449,407 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2022-09-28$0.42/sh−248,782→ 92,850,381 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2022-09-27$0.44/sh−98,364→ 93,099,163 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2022-09-15$0.50/sh−24,181→ 93,197,527 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2022-09-13$0.51/sh−18,181→ 93,221,708 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2022-09-12$0.53/sh−65,133→ 93,239,889 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2022-08-15$0.60/sh−2,094,168→ 93,305,022 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2022-08-12$0.66/sh−656,654→ 95,399,190 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2022-08-10$0.74/sh−361,633→ 96,055,844 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2022-08-09$0.76/sh−1,380,045→ 96,417,477 total
Sale
Dave Inc./DE$DAVE
Class A Common Stock
2022-08-08$0.77/sh−317,404→ 97,797,522 total
Award
Dave Inc./DE$DAVE
Class A Common Stock
2022-01-05+98,114,926→ 98,114,926 total
Conversion
Cue Health Inc.
Series B Preferred Stock
2021-09-28−3,485,535→ 0 total
Conversion
Cue Health Inc.
Common Stock
2021-09-28+3,485,535→ 3,485,535 total
Disposition to Issuer
DA32 Life Science Tech Acquisition Corp.
Class B Common Stock, par value $0.0001 per share
2021-08-05−30,000→ 4,665,000 total
Disposition to Issuer
DA32 Life Science Tech Acquisition Corp.
Class B Common Stock, par value $0.0001 per share
2021-08-05−701,250→ 4,695,000 total
Award
DA32 Life Science Tech Acquisition Corp.
Class A Common Stock
2021-07-30$10.00/sh+650,000→ 1,450,000 total
Purchase
DA32 Life Science Tech Acquisition Corp.
Class A Common Stock
2021-07-30$10.00/sh+800,000→ 800,000 total
Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2019-07-22+464,285→ 464,285 total
Conversion
Fulcrum Therapeutics, Inc.$FULC
Series B Preferred Stock
2019-07-22−3,250,000→ 0 total
Conversion
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2017-11-20+451,362→ 451,362 total
Conversion
X4 Pharmaceuticals, Inc$XFOR
Series D Convertible Preferred Stock
2017-11-20−1,540,500→ 0 total

Companies

Recent Filings

Address

2071 SAN ELIJO AVENUE

CARDIFF-BY-THE-SEA, CA, 92007

View on SEC.gov